Peer Review History: Impact of Combining Immune Checkpoint Inhibitors with Chemotherapy in the Management of Advanced Serous Endometrial Adenocarcinoma

Editor(s):

(1) Dr. Bhuvanesh Sukhlal Kalal, Research Scientist, College of Medicine, University of Kentucky, USA.

Reviewers:

(1) Baskaran Krishnan, Anna Medical College, University of Technology, Mauritius.

(2) Ashwii N, SKAMCH&RC, India.

Additional Reviewers:

Additional Reviewers: (Comments received after deadline)

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.25/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer Review Report_1 (Baskaran Krishnan, Mauritius) | File 1 | NA


Stage 2 | Peer Review Report_2 (Ashwii N, India) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | File 2


Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | NA


Stage 3 | Comment_Editor_1_v2 | File 1 | NA


Stage 3 | Revised_MS_v3_and_Feedback_v3 | File 1 | NA


Posted in Review History.